Health Condition 1: L811- Chloasma
Conditions
Interventions
None listed
Sponsors
National Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients suffering from classical clinical signs and symptoms of Vyanga 2. Patient of age 20 to 40 years irrespective of sex and religion
Exclusion criteria
Exclusion criteria: 1.Patients receiving hormone or corticosteroid therapy 2.Patients with history of endocrine disorders or allergies. 3.Patients taking depigmenting or whitening products (oral or topical) within the previous 6 weeks. 4.Pregnant or breast feeding mother 5.Subjects who are allergic to chemical compound in the Lepa or fragrance. 6.Using a medication that increases sensitivity to sunlight including doxycycline, minocycline, tetracycline, ciprofloxin, hydrochlorothiazide, and sulfonamides. 7.Usage of any new skincare products during the course of the study. 8.Facial/laser treatment within the last 3 months 9.Facial cosmetic surgery within the last 12 months 10.Physical skin conditions such as excessive hair, scarring, tattoos that might impair evaluations of the test sites
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Melasma Area and Severity Index (MASI) Score Severity of melasma in each of the four regions (forehead, right malar region, left malar region and chin) is assessed on percentage of the total area involved (A), darkness (D), and homogeneity (H). Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Color assessment of facial hyperpigmentation 2. Patients Global Assessment of facial hyperpigmentation 3. Dermatology life quality indexTimepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactDr Ravi Kumar
National Institute of Ayurveda
Outcome results
None listed